DermaCompare 一个使用了人工智能的皮肤癌诊断应用
在现有医疗应用之中，有一款应用，它使用了云人工智能技术，利用手机摄像头进行「全身摄影（Total Body Photography）」，检测黑色素瘤。这款应用就是 DermaCompare，可以在苹果商店里免费下载，由一家以色列公司 Emerald Medical Applications（MRLA）开发，已向 FDA 注册。这款应用符合 HIPPA（健康保险流通与责任法案，保护病患隐私），Emerald Medical 的首席执行官 Lior Wayne说道，下载了这款应用，利用专利比较算法，每个用户或医生就可以通过任何智能手机的摄像头来确认某种痣是否为黑色素瘤征兆。Wayne相信，DermaCompare 是唯一一个使用了人工智能的皮肤癌诊断应用。Take your own picture using your mobile device, and DermaCompare will indicate for your doctor the suspicious lesions across your body.
Regular monitoring and periodic photo shooting will enable DermaCompare to identify suspicious lesions, as well as changes in preexisting lesions, that require referring to a doctor for further treatment.
The image processing technology used by DermaCompare is very advanced and based on defense technologies, so the identification is immeasurably more accurate than other existing solutions worldwide. DermaCompare is the only currently available app capable of full body imaging and suspicious lesions comparison and monitoring.
The mole photos can be saved on DermaCompare’s cloud, to enable reliable comparison with each new photo. DermaCompare’s cloud is HIPAA-compliant and protected by strict information technology mechanisms.
页:
[1]